CIBC Private Wealth Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

CIBC Private Wealth Group’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-117,741	Closed	-$4.8M	–	1091
2021 Q1	$4.8M	Sell	117,741 -7,154	-6%	-$329K	0.01%	401
2020 Q4	$5.41M	Sell	124,895 -53,369	-30%	-$2.63M	0.01%	378
2020 Q3	$9.83M	Sell	178,264 -7,218	-4%	-$459K	0.03%	297
2020 Q2	$11.7M	Buy	185,482 +79,127	+74%	+$5.43M	0.06%	213
2020 Q1	$5.43M	Buy	106,355 +1,751	+2%	+$117K	0.02%	307
2019 Q4	$8.31M	Buy	+104,604	New	+$6.2M	0.03%	310
2018 Q2	–	Sell	-7	Closed	–	–	2135
2018 Q1	$0	Buy	+7	New	+$390	﹤0.01%	2112

Other funds holding GBT

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

CIBC Private Wealth Group's GBT Position: Q2 2021 in Review

CIBC Private Wealth Group sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2021, closing a stake of 117,741 shares — an estimated $4.8M sold.

CIBC Private Wealth Group first reported a position in GBT in Q1 2018 and held it in 7 quarters. The position peaked at $11.7M in Q2 2020. 191 funds tracked by Wall St. Rank hold GBT as of Q2 2021.

CIBC Private Wealth Group reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
CIBC Private Wealth Group sold 117,741 Global Blood Therapeutics, Inc. shares in Q2 2021, an estimated $4.8M.
CIBC Private Wealth Group first reported a position in Global Blood Therapeutics, Inc. in Q1 2018 and held it in 7 quarters.
CIBC Private Wealth Group's Global Blood Therapeutics, Inc. position peaked at $11.7M in Q2 2020.
191 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2021.

Based on CIBC Private Wealth Group's 13F filing for Q2 2021, filed 16 Aug 2021.